A theme concerning deteriorating performance in an integrated pharmaceuticals and food segment, including declining revenue and profit or segment losses due to the impact of voluntary product recalls and other factors. Focuses on the performance of the two businesses together and the impact of recalls, rather than on the pharmaceuticals or food business alone.